Telerehab Exerbrain: Bridging Physical and Cognitive Therapy in Stroke
Effects of Web-Based Physical-Cognitive Telerehabilitation Exergaming on Physical and Cognitive Performance in Chronic Stroke Survivors: Protocol for a Randomized Controlled Trial
1 other identifier
interventional
52
0 countries
N/A
Brief Summary
The goal of this clinical trial is to learn if a web-based exercise and cognitive training (physical-cognitive) program works to improve movements and brain function in adults with long-term stroke. It will also learn whether the program is safe and enjoyable. The main questions it aims to answer are: Does the program improve walking, balance, strength, and reduce fall risk? Does the program improve cognitive skills such as memory, attention, and problem-solving? Researchers will compare the online exercise-and-cognitive training program to usual care to see if the program leads to greater improvements. Participants will:
- Be randomly assigned to either the online training group or the usual care group
- If in the training group, complete the home-based program for 12 weeks.
- Take part in physical and cognitive tests before and after the program
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Feb 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2026
CompletedFirst Submitted
Initial submission to the registry
February 18, 2026
CompletedFirst Posted
Study publicly available on registry
March 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
March 3, 2026
February 1, 2026
9 months
February 18, 2026
February 25, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Executive function
Trail Making Test (TMT) part B-A will be evaluated at baseline and 3 months.
3 months
Fall risk
Fall risk will be assessed using the Timed Up and Go (TUG) test at baseline and 3 months. The time taken to complete TUG will be recorded in Sec.
3 months
Gait speed
10-Meter Walk test (10MWT) will be used to assessed gait speed at baseline and 3 months.
3 months.
Secondary Outcomes (7)
Global cognitive function
3 months
Attention
3 months
Motor function
3 months
Balance
3 months
Muscle strength
3 months
- +2 more secondary outcomes
Study Arms (2)
Web-Based Physical-Cognitive Telerehabilitation Exergaming
EXPERIMENTALPhysical-cognitive exergame via web-based platform at home setting for 60 min/session, 3 sessions/week for 12 weeks.
Control
NO INTERVENTIONInterventions
Perform a physical-cognitive exergame via ExerbrainCMU web-based platform at home setting for 60 min/session, 3 sessions/week for 12 weeks.
Eligibility Criteria
You may qualify if:
- diagnosed with ischemic or hemorrhagic stroke at least 6 months before enrollment
- aged between 20 and 80 years
- able to walk at least 10 meters with or without assistive devices
- able to perform sit-to-stand safely with or without assistive devices
- can see the screen of a tablet or notebook computer at a distance of at least 60 cm
- have a stable medical condition and can follow study instructions
- frequent users of a mobile phone, tablet, or notebook computers
You may not qualify if:
- have medical conditions or complications that would be unsafe to exercise
- have neglect, impaired communication, or uncorrected visual problems \[30\], or - have severe spasticity of the upper or lower extremities (Modified Ashworth Scale ≥ 3)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Puntarik Keawtep
Chiang Mai Uiversity
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
February 18, 2026
First Posted
March 3, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
March 1, 2027
Last Updated
March 3, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual Participant Data (IPD) will not be shared because the informed consent obtained from participants did not include permission for public data sharing. Additionally, due to the sensitive nature of the clinical data and the potential risk of participant re-identification, data sharing is not planned.